The emergence of GLP-1 therapies marks a pivotal moment in healthcare innovation.
In UpToDate® clinical decision support solution, searches for obesity drug treatments have surged, and non-diabetes-related GLP-1 prescriptions have increased by 1961% in the last five years. These therapies are shaping trends in almost every industry, and none more so than healthcare.
With patients now getting healthcare information from many sources outside of their medical visits, clinicians are adapting to new approaches to help manage their expectations and identify the best path forward that meets their needs and is still appropriate for clinical indications.
Evidence-based clinical information equips clinicians to advise patients
While advancements like GLP-1s have the potential to redefine clinical approaches to public health concerns, they also are redefining healthcare relationships, including:
- How patients interact with information and view their role in their care.
- How clinicians interact with patients and manage their expectations.
- How the healthcare ecosystem responds to patient demand.
The success of innovative therapies – and healthcare professionals’ ability to integrate them safely and effectively into their practice – relies on accessible, evidence-based, and equitable clinical information.
When healthcare leaders and policymakers better equip clinicians to advise, treat, and educate patients, it can have a system-wide effect on outcomes, experience, and satisfaction for patients and professionals.
Download our expert whitepaper, “Beyond the prescription: What GLP-1s reveal about healthcare’s changing power dynamic,” to learn more.
